Avantor, Inc. (NYSE:AVTR) Receives Consensus Rating of “Hold” from Analysts

Avantor, Inc. (NYSE:AVTR) has been assigned a consensus recommendation of “Hold” from the seventeen research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $13.60.

A number of analysts have recently weighed in on the stock. TD Cowen cut their price target on shares of Avantor from $14.00 to $12.00 and set a “hold” rating for the company in a report on Wednesday, January 7th. JPMorgan Chase & Co. restated a “neutral” rating and set a $12.00 price objective (down from $14.00) on shares of Avantor in a research report on Thursday, October 30th. Bank of America cut Avantor from a “buy” rating to a “neutral” rating and set a $13.00 target price for the company. in a research note on Monday, December 15th. UBS Group set a $12.00 target price on Avantor in a report on Thursday, October 30th. Finally, Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research note on Monday, December 29th.

Insider Transactions at Avantor

In related news, Director Gregory L. Summe purchased 100,000 shares of Avantor stock in a transaction dated Thursday, October 30th. The shares were bought at an average cost of $11.25 per share, for a total transaction of $1,125,000.00. Following the purchase, the director owned 300,000 shares in the company, valued at approximately $3,375,000. This trade represents a 50.00% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Sanjeev K. Mehra purchased 350,000 shares of the firm’s stock in a transaction that occurred on Friday, December 5th. The shares were bought at an average cost of $11.09 per share, for a total transaction of $3,881,500.00. Following the completion of the acquisition, the director directly owned 350,000 shares in the company, valued at $3,881,500. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 1.20% of the company’s stock.

Institutional Trading of Avantor

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Avantor by 288.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock valued at $28,000 after acquiring an additional 1,263 shares in the last quarter. Vident Advisory LLC acquired a new position in Avantor in the 1st quarter worth about $419,000. Royal Bank of Canada raised its position in Avantor by 104.3% in the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock valued at $3,302,000 after purchasing an additional 104,022 shares during the last quarter. Federation des caisses Desjardins du Quebec boosted its stake in shares of Avantor by 37.5% during the first quarter. Federation des caisses Desjardins du Quebec now owns 120,169 shares of the company’s stock valued at $1,948,000 after purchasing an additional 32,777 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in shares of Avantor during the first quarter valued at about $4,863,000. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

AVTR opened at $12.41 on Monday. The firm has a market cap of $8.46 billion, a P/E ratio of -95.43, a price-to-earnings-growth ratio of 4.30 and a beta of 0.93. Avantor has a 52-week low of $10.62 and a 52-week high of $23.32. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.96 and a current ratio of 1.49. The business’s fifty day moving average is $11.44 and its 200-day moving average is $12.59.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The company had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.65 billion. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The firm’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same period last year, the firm earned $0.26 EPS. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Sell-side analysts expect that Avantor will post 1.06 EPS for the current fiscal year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.